Log In
Sign Up
Malignant lymphomas; Hodgkin's disease; lymphocytic lymphoma; Burkitt's lymphoma; multiple myeloma; leukemias; advanced mycosis fungoides; disseminated neuroblastoma; enocarcinoma of the ovary; retinoblastoma; carcinoma of the breast; biopsy proven "minimal change" nephrotic syndrome in children.
Intravenously: 40-50 mg/kg in divided doses over a period of 2-5 days or IV 10-15 mg/kg given every 7-10 days or 3 -5 mg/kg twice weekly. Orally: 1-5 mg/kg/day for both initial and maintenance dosing. These are doses for oncolytic drug therapy for patients with no hematologic deficiency.
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Cycloxan Injection 200mg 1 KES231.00
Cycloxan Injection 500mg 1 KES381.00
Cycloxan Injection 1gm 1 KES694.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us